Ignite Creation Date:
2024-07-17 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06492239
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-07-01
Brief Title:
Emergency Stroke Unit for Acute Cerebrovascular Events ESU-ACE-A
Sponsor:
Beijing Tiantan Hospital
Organization:
Beijing Tiantan Hospital
Study Overview
Official Title:
Emergency Stroke Unit for Acute Cerebrovascular Events--A Prospective Multicenter Week-wise Randomized Controlled Trial ESU-ACE-A
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To compare the door-to-needle time of patients with hyperacute ischemic stroke within 45 hours after the onset of symptoms managed in a standard stroke unit adherent to guidelines versus managed in Emergency Stroke Unit a new stroke unit based on low-field magnetic resonance imaging
Detailed Description:
Intravenous thrombolysis is an effective reperfusion therapy for patients with acute ischemic stroke Faster door-to-needle time DNT is associated with significantly better clinical outcomes With the development of low-field magnetic resonance imaging it is poised to play an increasingly significant role in the early diagnosis and management of acute ischemic stroke This prospective multicenter week-wise randomized controlled trial will compare the door-to-needle time of patients with hyperacute ischemic stroke within 45 hours after the onset of symptoms managed in a standard stroke unit adherent to guidelines versus managed in Emergency Stroke Unit a new stroke unit based on low-field magnetic resonance imaging
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None